590 related articles for article (PubMed ID: 33081348)
21. Copper in the brain and Alzheimer's disease.
Hung YH; Bush AI; Cherny RA
J Biol Inorg Chem; 2010 Jan; 15(1):61-76. PubMed ID: 19862561
[TBL] [Abstract][Full Text] [Related]
22. Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease.
Kim N; Lee HJ
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299316
[TBL] [Abstract][Full Text] [Related]
23. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease.
House E; Collingwood J; Khan A; Korchazkina O; Berthon G; Exley C
J Alzheimers Dis; 2004 Jun; 6(3):291-301. PubMed ID: 15201484
[TBL] [Abstract][Full Text] [Related]
24. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
Tõugu V; Tiiman A; Palumaa P
Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
[TBL] [Abstract][Full Text] [Related]
25. Role of metals in Alzheimer's disease.
Das N; Raymick J; Sarkar S
Metab Brain Dis; 2021 Oct; 36(7):1627-1639. PubMed ID: 34313926
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory potency of 4- substituted sampangine derivatives toward Cu
Su C; Chen Y; Chen K; Li W; Tang H
Neurochem Int; 2020 Oct; 139():104794. PubMed ID: 32650027
[TBL] [Abstract][Full Text] [Related]
27. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
28. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease.
Wang P; Wang ZY
Ageing Res Rev; 2017 May; 35():265-290. PubMed ID: 27829171
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
Han J; Du Z; Lim MH
Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
[TBL] [Abstract][Full Text] [Related]
30. Rebalancing metal dyshomeostasis for Alzheimer's disease therapy.
Yang GJ; Liu H; Ma DL; Leung CH
J Biol Inorg Chem; 2019 Dec; 24(8):1159-1170. PubMed ID: 31486954
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic redistribution of metal ions to treat Alzheimer's disease.
Crouch PJ; Barnham KJ
Acc Chem Res; 2012 Sep; 45(9):1604-11. PubMed ID: 22747493
[TBL] [Abstract][Full Text] [Related]
32. Role of metal dyshomeostasis in Alzheimer's disease.
Bonda DJ; Lee HG; Blair JA; Zhu X; Perry G; Smith MA
Metallomics; 2011 Mar; 3(3):267-70. PubMed ID: 21298161
[TBL] [Abstract][Full Text] [Related]
33. Metals, oxidative stress and neurodegenerative disorders.
Jomova K; Vondrakova D; Lawson M; Valko M
Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
[TBL] [Abstract][Full Text] [Related]
34. Amyloid beta-Cu2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals.
Nadal RC; Rigby SE; Viles JH
Biochemistry; 2008 Nov; 47(44):11653-64. PubMed ID: 18847222
[TBL] [Abstract][Full Text] [Related]
35. Metal-Organic Frameworks Harness Cu Chelating and Photooxidation Against Amyloid β Aggregation in Vivo.
Yu D; Guan Y; Bai F; Du Z; Gao N; Ren J; Qu X
Chemistry; 2019 Mar; 25(14):3489-3495. PubMed ID: 30601592
[TBL] [Abstract][Full Text] [Related]
36. Copper-Targeting Approaches in Alzheimer's Disease: How To Improve the Fallouts Obtained from in Vitro Studies.
Esmieu C; Guettas D; Conte-Daban A; Sabater L; Faller P; Hureau C
Inorg Chem; 2019 Oct; 58(20):13509-13527. PubMed ID: 31247877
[TBL] [Abstract][Full Text] [Related]
37. Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents.
Du Z; Li M; Ren J; Qu X
Acc Chem Res; 2021 May; 54(9):2172-2184. PubMed ID: 33881820
[TBL] [Abstract][Full Text] [Related]
38. Cu
Du C; Feng W; Dai X; Wang J; Geng D; Li X; Chen Y; Zhang J
Small; 2022 Sep; 18(39):e2203031. PubMed ID: 36008124
[TBL] [Abstract][Full Text] [Related]
39. Zinc takes the center stage: its paradoxical role in Alzheimer's disease.
Cuajungco MP; Fagét KY
Brain Res Brain Res Rev; 2003 Jan; 41(1):44-56. PubMed ID: 12505647
[TBL] [Abstract][Full Text] [Related]
40. The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.
Chen LL; Fan YG; Zhao LX; Zhang Q; Wang ZY
Bioorg Chem; 2023 Feb; 131():106301. PubMed ID: 36455485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
